Home » Stocks » ZSAN

Zosano Pharma Corporation (ZSAN)

Stock Price: $0.580 USD 0.013 (2.22%)
Updated November 25, 4:00 PM EST - Market closed
After-hours: $0.579 -0.002 (-0.26%) Nov 25, 7:33 PM

Stock Price Chart

Key Info

Market Cap 39.78M
Revenue (ttm) n/a
Net Income (ttm) -34.21M
Shares Out 68.58M
EPS (ttm) -0.73
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 25
Last Price $0.580
Previous Close $0.567
Change ($) 0.013
Change (%) 2.22%
Day's Open 0.580
Day's Range 0.552 - 0.588
Day's Volume 1,794,285
52-Week Range 0.328 - 1.970

More Stats

Market Cap 39.78M
Enterprise Value 13.52M
Earnings Date (est) Mar 18, 2021
Ex-Dividend Date n/a
Shares Outstanding 68.58M
Float 65.92M
EPS (basic) -0.94
EPS (diluted) -0.73
FCF / Share -0.53
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 5.76M
Short Ratio 1.37
Short % of Float 8.74%
Beta 3.55
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 1.09
Revenue n/a
Operating Income -33.57M
Net Income -34.21M
Free Cash Flow -41.44M
Net Cash 26.26M
Net Cash / Share 0.38
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -35.83%
ROE -104.27%
ROIC -93.30%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (3)

Buy 3
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(215.52% upside)
Current: $0.580
Target: 1.83
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth-----89.06%-32.68%-
Gross Profit----0.312.764.25
Operating Income-37.20-35.38-28.37-28.63-26.37-12.61-7.97
Net Income-37.59-35.36-29.11-29.83-28.43-14.24-5.61
Shares Outstanding16.389.451.730.690.570.260.26
Earnings Per Share-2.29-3.74-16.82-43.36-49.80-55.60-22.00
Operating Cash Flow-34.82-29.12-26.84-25.69-24.16-10.92-3.72
Capital Expenditures-11.76-5.48-1.22-0.22-0.43-1.18-0.90
Free Cash Flow-46.58-34.60-28.06-25.91-24.59-12.09-4.62
Cash & Equivalents6.7723.4612.1115.0436.971.255.98
Total Debt17.726.836.6912.5415.2722.0613.32
Net Cash / Debt-10.9516.635.422.5021.70-20.81-7.34
Book Value9.3918.717.054.4926.50-13.400.48
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Zosano Pharma Corporation
Country United States
Employees 56
CEO Steven Lo

Stock Information

Ticker Symbol ZSAN
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: ZSAN
IPO Date January 27, 2015


Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics to patients suffering from migraine using its intracutaneous microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California.